ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
|
|
dolcevita
|
181 |
79K |
9 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
181
|
79K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
|
|
dolcevita
|
181 |
79K |
8 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
181
|
79K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
|
|
dolcevita
|
181 |
79K |
14 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
181
|
79K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
|
|
dolcevita
|
181 |
79K |
10 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
181
|
79K
|
10
|
|
ASX - By Stock
|
SS1 Mining |
Re:
Largest silver play ASX
|
|
dolcevita
|
151 |
109K |
0 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
151
|
109K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
dolcevita
|
943 |
407K |
10 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
943
|
407K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
dolcevita
|
943 |
407K |
18 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
943
|
407K
|
18
|
|
ASX - By Stock
|
WC8 |
Re:
Ann: LEIA RETURNS WIDE INTERSECTIONS AND HIGH-GRADE ZONES
|
|
dolcevita
|
180 |
77K |
6 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
180
|
77K
|
6
|
|
ASX - By Stock
|
WC8 |
Re:
Ann: LEIA RETURNS WIDE INTERSECTIONS AND HIGH-GRADE ZONES
|
|
dolcevita
|
180 |
77K |
4 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
180
|
77K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
dolcevita
|
943 |
407K |
9 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
943
|
407K
|
9
|
|
ASX - By Stock
|
AUG |
Re:
Ann: Minnie Springs High Grade Cu-Mo Porphyry Targeting
|
|
dolcevita
|
9 |
4.1K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
9
|
4.1K
|
1
|
|
ASX - By Stock
|
DEG |
Re:
Gold Price
|
|
dolcevita
|
633 |
261K |
17 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
633
|
261K
|
17
|
|
ASX - By Stock
|
SS1 Mining |
Re:
Largest silver play ASX
|
|
dolcevita
|
151 |
109K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
151
|
109K
|
1
|
|
ASX - By Stock
|
SS1 |
Re:
Ann: Ag Intercepts up to 6216g/t in high grade zone
|
|
dolcevita
|
14 |
10K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
14
|
10K
|
3
|
|
ASX - By Stock
|
DRE |
Re:
Ann: Tiger Cu-Au-Zn-Ag Gossan Confirmed Over 500m
|
|
dolcevita
|
54 |
24K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
54
|
24K
|
3
|
|
ASX - By Stock
|
DRE |
Re:
Ann: Tiger Cu-Au-Zn-Ag Gossan Confirmed Over 500m
|
|
dolcevita
|
54 |
24K |
4 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
54
|
24K
|
4
|
|
ASX - By Stock
|
SS1 |
Re:
Ann: Ag Intercepts up to 6216g/t in high grade zone
|
|
dolcevita
|
14 |
10K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
14
|
10K
|
3
|
|
ASX - By Stock
|
BGD |
Re:
General Discussion Thread
|
|
dolcevita
|
25 |
10K |
2 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
25
|
10K
|
2
|
|
ASX - By Stock
|
WC8 |
Re:
WILDCAT ARTICLE
|
|
dolcevita
|
128 |
81K |
1 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
128
|
81K
|
1
|
|
ASX - By Stock
|
WC8 |
Re:
Ann: LEIA RETURNS WIDE INTERSECTIONS AND HIGH-GRADE ZONES
|
|
dolcevita
|
180 |
77K |
5 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
180
|
77K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
12 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
1.0K
|
438K
|
12
|
|
ASX - By Stock
|
DEG |
Re:
DEG
|
|
dolcevita
|
372 |
187K |
3 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
372
|
187K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
1.0K
|
438K
|
0
|
|
ASX - By Stock
|
AUG |
Re:
Ann: Minnie Springs High Grade Cu-Mo Porphyry Targeting
|
|
dolcevita
|
9 |
4.1K |
6 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
9
|
4.1K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
438K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
16 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
438K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
16 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
438K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
dolcevita
|
225 |
84K |
15 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
225
|
84K
|
15
|
|
ASX - By Stock
|
DEG |
Re:
Gold Price
|
|
dolcevita
|
633 |
261K |
10 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
633
|
261K
|
10
|
|
ASX - By Stock
|
DEG |
Re:
DEG
|
|
dolcevita
|
372 |
187K |
8 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
372
|
187K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
dolcevita
|
88 |
35K |
8 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
88
|
35K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
dolcevita
|
88 |
35K |
6 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
88
|
35K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
dolcevita
|
88 |
35K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
88
|
35K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
dolcevita
|
245 |
94K |
1 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
245
|
94K
|
1
|
|
ASX - By Stock
|
LYC |
Re:
Interesting
|
|
dolcevita
|
397 |
151K |
1 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
397
|
151K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
1.0K
|
438K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.0K
|
438K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
31 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.0K
|
438K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
6 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1.0K
|
438K
|
6
|
|
ASX - By Stock
|
DEG |
Re:
DeGrey F’s Foreign Investors and F’s themselves
|
|
dolcevita
|
30 |
15K |
1 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
30
|
15K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
1 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1.0K
|
438K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
7 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
1.0K
|
438K
|
7
|
|
ASX - By Stock
|
DEG |
Re:
DeGrey F’s Foreign Investors and F’s themselves
|
|
dolcevita
|
30 |
15K |
0 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
30
|
15K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dolcevita
|
1.0K |
438K |
19 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
1.0K
|
438K
|
19
|
|
ASX - By Stock
|
WC8 |
Re:
Ann: Luke Discovery Returns High Grade Results
|
|
dolcevita
|
56 |
32K |
5 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
56
|
32K
|
5
|
|
ASX - By Stock
|
BGD |
Re:
Ann: Presentation to London 121 Mining Conference
|
|
dolcevita
|
16 |
6.6K |
2 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
16
|
6.6K
|
2
|
|
ASX - By Stock
|
DEG |
Re:
DeGrey F’s Foreign Investors and F’s themselves
|
|
dolcevita
|
30 |
15K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
30
|
15K
|
0
|
|
ASX - By Stock
|
WC8 |
Re:
Ann: Luke Discovery Returns High Grade Results
|
|
dolcevita
|
56 |
32K |
7 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
56
|
32K
|
7
|
|
ASX - By Stock
|
WC8 |
Re:
Ann: Luke Discovery Returns High Grade Results
|
|
dolcevita
|
56 |
32K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
56
|
32K
|
0
|
|
ASX - By Stock
|
DEG |
Re:
Gold Price
|
|
dolcevita
|
633 |
261K |
3 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
633
|
261K
|
3
|
|